BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 19435917)

  • 1. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response.
    Szokalska A; Makowski M; Nowis D; Wilczynski GM; Kujawa M; Wójcik C; Mlynarczuk-Bialy I; Salwa P; Bil J; Janowska S; Agostinis P; Verfaillie T; Bugajski M; Gietka J; Issat T; Glodkowska E; Mrówka P; Stoklosa T; Hamblin MR; Mróz P; Jakóbisiak M; Golab J
    Cancer Res; 2009 May; 69(10):4235-43. PubMed ID: 19435917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
    Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
    Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme oxygenase-1 protects tumor cells against photodynamic therapy-mediated cytotoxicity.
    Nowis D; Legat M; Grzela T; Niderla J; Wilczek E; Wilczynski GM; Głodkowska E; Mrówka P; Issat T; Dulak J; Józkowicz A; Waś H; Adamek M; Wrzosek A; Nazarewski S; Makowski M; Stokłosa T; Jakóbisiak M; Gołab J
    Oncogene; 2006 Jun; 25(24):3365-74. PubMed ID: 16462769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy.
    Firczuk M; Gabrysiak M; Barankiewicz J; Domagala A; Nowis D; Kujawa M; Jankowska-Steifer E; Wachowska M; Glodkowska-Mrowka E; Korsak B; Winiarska M; Golab J
    Cell Death Dis; 2013 Jul; 4(7):e741. PubMed ID: 23887632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macroscopic singlet oxygen modeling for dosimetry of Photofrin-mediated photodynamic therapy: an in-vivo study.
    Qiu H; Kim MM; Penjweini R; Zhu TC
    J Biomed Opt; 2016 Aug; 21(8):88002. PubMed ID: 27552311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice.
    Makowski M; Grzela T; Niderla J; ŁAzarczyk M; Mróz P; Kopeé M; Legat M; Strusińska K; Koziak K; Nowis D; Mrówka P; Wasik M; Jakóbisiak M; Gołab J
    Clin Cancer Res; 2003 Nov; 9(14):5417-22. PubMed ID: 14614028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.
    Domagala A; Stachura J; Gabrysiak M; Muchowicz A; Zagozdzon R; Golab J; Firczuk M
    BMC Cancer; 2018 Feb; 18(1):210. PubMed ID: 29463237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
    Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
    Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor.
    Golab J; Nowis D; Skrzycki M; Czeczot H; Baranczyk-Kuzma A; Wilczynski GM; Makowski M; Mroz P; Kozar K; Kaminski R; Jalili A; Kopec' M; Grzela T; Jakobisiak M
    J Biol Chem; 2003 Jan; 278(1):407-14. PubMed ID: 12409296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors.
    Cecic I; Parkins CS; Korbelik M
    Photochem Photobiol; 2001 Nov; 74(5):712-20. PubMed ID: 11723800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl-2 increases emptying of endoplasmic reticulum Ca2+ stores during photodynamic therapy-induced apoptosis.
    Granville DJ; Ruehlmann DO; Choy JC; Cassidy BA; Hunt DW; van Breemen C; McManus BM
    Cell Calcium; 2001 Nov; 30(5):343-50. PubMed ID: 11733941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative modification induced by photodynamic therapy with Photofrin®II and 2-methoxyestradiol in human ovarian clear carcinoma (OvBH-1) and human breast adenocarcinoma (MCF-7) cells.
    Saczko J; Choromańska A; Rembiałkowska N; Dubińska-Magiera M; Bednarz-Misa I; Bar J; Marcinkowska A; Kulbacka J
    Biomed Pharmacother; 2015 Apr; 71():30-6. PubMed ID: 25960212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolyporphin: a natural product from cyanobacteria with potent photosensitizing activity against tumor cells in vitro and in vivo.
    Morlière P; Mazière JC; Santus R; Smith CD; Prinsep MR; Stobbe CC; Fenning MC; Golberg JL; Chapman JD
    Cancer Res; 1998 Aug; 58(16):3571-8. PubMed ID: 9721863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the anti-tumour effects of Photofrin-based photodynamic therapy by localized treatment with G-CSF.
    Gołab J; Wilczyński G; Zagozdzon R; Stokłosa T; Dabrowska A; Rybczyńska J; Wasik M; Machaj E; Ołda T; Kozar K; Kamiński R; Giermasz A; Czajka A; Lasek W; Feleszko W; Jakóbisiak M
    Br J Cancer; 2000 Apr; 82(8):1485-91. PubMed ID: 10780531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of photodynamic therapy responses elicited in A431 cells containing intracellular organelle-localized photofrin.
    Hsieh YJ; Yu JS; Lyu PC
    J Cell Biochem; 2010 Nov; 111(4):821-33. PubMed ID: 20665537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
    Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ
    Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular determinants of photodynamic therapy for lung cancers.
    Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
    Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic enhancement of vascular-targeted photodynamic therapy by inhibiting proteasomal function.
    Li Z; Agharkar P; Chen B
    Cancer Lett; 2013 Oct; 339(1):128-34. PubMed ID: 23872275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF potentiates anticancer activity of bortezomib (Velcade) through reduced expression of proteasome subunits and dysregulation of unfolded protein response.
    Nowis D; McConnell EJ; Dierlam L; Palamarchuk A; Lass A; Wójcik C
    Int J Cancer; 2007 Jul; 121(2):431-41. PubMed ID: 17373661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Cellular Uptake and Photodynamic Effect with Amphiphilic Fluorinated Porphyrins: The Role of Sulfoester Groups and the Nature of Reactive Oxygen Species.
    Pucelik B; Sułek A; Drozd A; Stochel G; Pereira MM; Pinto SMA; Arnaut LG; Dąbrowski JM
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.